Journals / Journal of Medicine and Palliative Care / 2023 / Cilt: 4 Sayı: 2

Cardiovascular risk assessment with pulse wave velocity, intima media thickness, and flow-mediated dilatation in patients with idiopathic pulmonary fibrosis

İdiyopatik pulmoner fibrozisli hastalarda nabız dalga hızı, intima media kalınlığı ve akım aracılı dilatasyon ile kardiyovasküler risk değerlendirmesi

Pages
176–182
Publication Date
2023-03-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A sustained inflammatory response may have play an important role in the process of atherosclerosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The underlying mechanism of fibrotic lung diseases predisposing to coronary artery disease is not yet clear.
📊
Key Findings & Data:Chronic inflammation may contribute to atherosclerosis and play a role in increased cardiovascular risk.
💡
Conclusion & Impact:A sustained inflammatory response may have play an important role in the process of atherosclerosis.
🔬Design:Modeling & Simulation
📍Scope:2019 Verileri
⚙️Variables:kardiyovasküler hastalık · koroner arter hastalığı · pulmoner fibroz

Abstract

Aim: The underlying mechanism of fibrotic lung diseases predisposing to coronary artery disease is not yet clear. Chronic inflammation may contribute to atherosclerosis and play a role in increased cardiovascular risk. To study investigate subclinical atherosclerosis by measuring carotid femoral pulse wave velocity (PWV), carotid intima media thickness (CIMT), and flow-mediated dilatation (FMD) in patients with idiopathic pulmonary fibrosis (IPF). Material and Method: This cross-sectional study consisted of 55 newly diagnosed IPF patients and 55 healthy controls between September 2019 and September 2021. Cardiovascular Risk Assessment was evaluated by endothelial function measured by FMD, CIMT measured by carotid doppler ultrasonography, and arterial stiffness measured by PWV. Results: In multivariable regression models, the presence of IPF was common independent predictor of CIMT (β±SE=0.18±0.05, p=0.002), log(FMD) (β±SE=–0.15±0.04, p<0.001) and log(PWD) (β±SE=0.16±0.03, p<0.001). An increase log(PWV) levels were common independent predictors of CIMT and log(FMD). The levels of CRP were positively correlated with CIMT (r=0.359, p=0.009) and PWV (r=0.338, p=0.018) levels, while it was negatively correlated with FMD levels (r=-0.372, p=0.004). Conclusions: IPF patients have elevated risk of endothelial dysfunction and atherosclerosis. A sustained inflammatory response may have play an important role in the process of atherosclerosis.

Özet

Amaç: Koroner arter hastalığına yatkınlık oluşturan fibrotik akciğer hastalıklarının altında yatan mekanizma henüz netlik kazanmamıştır. Kronik inflamasyon ateroskleroza katkıda bulunabilir ve kardiyovasküler riskin artmasında rol oynayabilir. Bu çalışmada, idiyopatik pulmoner fibrozlu (IPF) hastalarda karotis-femoral nabız dalga hızı (PWV), karotis intima media kalınlığı (CIMT) ve akım aracılı dilatasyon (FMD) ölçerek subklinik aterosklerozu araştırmayı amaçladık. Metod: Bu kesitsel çalışma, Eylül 2019 ile Eylül 2021 tarihleri arasında yeni tanı almış 55 IPF hastası ve 55 sağlıklı kontrolden oluştu. Kardiyovasküler Risk Değerlendirmesi, FMD ile ölçülen endotelyal fonksiyon, karotis doppler ultrasonografi ile ölçülen CIMT ve PWV ile ölçülen arteriyel sertlik ile değerlendirildi. Bulgular: Çok değişkenli regresyon modellerinde, IPF'nin varlığı CIMT (β ± SE = 0.18 ± 0.05, p = 0.002), log(FMD) (β ± SE = –0.15 ± 0.04, p < 0.001) ve log(PWD) (β ± SE = 0.16 ± 0.03, p < 0.001) için ortak bağımsız prediktör olarak saptandı. Artan log(PWV) seviyeleri, artan CIMT ve log(FMD) için ortak bağımsız öngörücüler idi. CRP seviyeleri ile CIMT (r = 0.359, p = 0.009) ve PWV (r = 0.338, p = 0.018) seviyeleri arasında pozitif korelasyon saptandı, FMD seviyeleri ile negatif korelasyon belirlendi (r = -0.372, p = 0.004). Sonuç: IPF hastalarında endotel disfonksiyonu ve ateroskleroz riski yüksektir. Sürekli bir inflamatuar yanıt, ateroskleroz sürecinde önemli bir rol oynamış olabilir.

🔖

Cite This Article

ALTINTAŞ, M. S., YÜKSEL, Y., DEMIRCI, D., RAKİCİ, T., DEMİRKOL, B., KARABAĞ, T., ÇETİNKAYA, E. (2023). Cardiovascular risk assessment with pulse wave velocity, intima media thickness, and flow-mediated dilatation in patients with idiopathic pulmonary fibrosis. Journal of Medicine and Palliative Care, Cilt: 4 Sayı: 2, 176–182. https://ajindex.com/articles/908047

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. an official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198: e44-e68. Agrawal A, Verma I, Shah V, Agarwal A, Sikachi RR. Cardiac manifestations of idiopathic pulmonary fibrosis. Intractable Rare Dis Res 2016; 5: 70-5.
  2. Dalleywater W, Powell HA, Hubbard RB, Navaratnam V. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest 2015; 147: 150-6.
  3. Kreuter M, Ehlers-Tenenbaum S, Palmowski K, et al. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One 2016; 11: e0151425. Summerhill VI, Grechko AV, Yet SF, Sobenin IA, Orekhov AN. The atherogenic role of circulating modified lipids in atherosclerosis. Int J Mol Sci 2019; 20: 3561. Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound 2015; 13: 46. Gimbrone MA, Jr., Garcia-Cardena G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016; 118: 620-36.
  4. Park KH, Park WJ. Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches. J Korean Med Sci 2015; 30: 1213-25.
  5. Cicchitto G, Musella V, Acitorio M, et al. Idiopathic pulmonary fibrosis and coronary artery disease. Multidiscip Respir Med 2014; 9: 31. Panagiotou M, Church AC, Johnson MK, Peacock AJ. Pulmonary vascular and cardiac impairment in interstitial lung disease. Eur Respir Rev 2017; 26: 16053. Nathan SD, Basavaraj A, Reichner C, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med 2010; 104: 1035-41. van Cleemput J, Sonaglioni A, Wuyts WA, Bengus M, Stauffer JL, Harari S. Idiopathic pulmonary fibrosis for cardiologists: differential diagnosis, cardiovascular comorbidities, and patient management. Adv Ther 2019; 36: 298-317.
  6. Tarbell J, Mahmoud M, Corti A, Cardoso L, Caro C. The role of oxygen transport in atherosclerosis and vascular disease. J R Soc Interface 2020; 17: 20190732. Camare C, Pucelle M, Negre-Salvayre A, Salvayre R. Angiogenesis in the atherosclerotic plaque. Redox Biol 2017; 12: 18-34.
  7. Cui A, Anhenn O, Theegarten D, et al. Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration 2010; 80: 372-8.
  8. Ziora D, Jastrzebski D, Adamek M, et al. Circulating concentration of markers of angiogenic activity in patient